Clinical Trial Update: A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating IBI362 in adults with poorly controlled Type 2 diabetes mellitus managed by diet and exercise has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• IBI362

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED